IRIN Examines Potential Rollout of HIV/AIDS Vaccine
October 24, 2013
An IRIN analysis examines how nations need to prepare for the distribution of a future HIV/AIDS vaccine. "Increased attention to the delivery of HIV prevention and treatment programs is needed to prepare communities for a potential rollout of a vaccine, which will most probably be partially effective, experts say," IRIN writes. The analysis highlights ongoing vaccine research and quotes several experts, including Mitchell Warren, executive director of AVAC; Michael Merson, director of the Global Health Institute at Duke University; Naresh Pratap Kc, director of Nepal's National Centre for AIDS and Sexually Transmitted Disease Control; and a UNAIDS spokesperson. Those interviewed discuss lessons learned from other vaccines, donor community awareness, HIV testing methods, and the need for outreach to "communities who carry the heaviest burden of HIV risk and infection," according to IRIN (10/23).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)